Clinical Trial Update: Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating immune responses to immunization with keyhole limpet hemocyanin delivered by scarification and intradermal routes in individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Keyhole Limpet Hemocyanin (Keyhole limpet hemocyanin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED